Medical Breakthrough: Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial

“An experimental, individualized therapeutic cancer #vaccine that uses messenger RNA (mRNA) to treat #pancreaticcancer continues to show potential in a small patient group. Follow-up results from a phase 1 clinical trial show that nearly 90% of people whose immune systems responded to the vaccine were still alive up to six years after receiving the last treatment”

https://bit.ly/4e0FRGJ

Experimental drug doubles one-year survival in #pancreaticcancer. The drug, elraglusib, targets the protective web that pancreatic tumors build around themselves, thus helping immune molecules and chemotherapy better penetrate the tumors.
https://buff.ly/Ng6I0ey
Experimental drug doubles one-year survival in pancreatic cancer

A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.

Live Science

This is such good news for the cancer with the lowest survival rate. Too bad the pseudodocs in HHS and CDC don't believe in mRNA vaccines.

https://www.nbcnews.com/health/cancer/pancreatic-cancer-mrna-vaccine-shows-lasting-results-early-trial-rcna331969

#medicine #vaccine #mRNA #PancreaticCancer

Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

NBC News

@jeridansky @tadbithuman lots of people are yes!
Check out eg Eithne Costello's work here in the UK, she's working on using diabetes symptoms that can be a warning sign for a small number of people, for early detection.
Inigo Martincorena at Wellcome in Cambridge also works on early pre-cancer lesions called PanINs, to see if we can spot it before it gets going. Two that spring to mind.

Cancer Research UK funds more pancreatic cancer research projects than any of the pancreatic-dedicated charities here (and funds research into fundamental biology underpinning all cancer types, plus trials, infrastructure etc.)
#CancerResearch #pancreaticCancer

Keep in mind that this is a Phase I trial, which is designed to test tolerability/safety (side effects). The number of participants is very small. However, for early stage #PancreaticCancer, any promising trearment is very exciting.
Next will be Phase II (dosing and effectiveness), and Phase III after that (does it work, what are the side effects, compare to other treatments).
https://www.nbcnews.com/health/cancer/pancreatic-cancer-mrna-vaccine-shows-lasting-results-early-trial-rcna331969
Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

NBC News

Two New Drugs Offer Hope for Pancreatic Cancer
New experimental medications seem to extend survival with the hard-to-treat cancer.

https://time.com/article/2026/04/14/new-promise-for-treating-pancreatic-cancer/

#PancreaticCancer

Two New Drugs Offer Hope for Pancreatic Cancer

New experimental medications seem to extend survival with the hard-to-treat cancer.

Time

Ex-Senator Ben Sasse Displays Visible Toll of Experimental Cancer Treatment

Former Senator Ben Sasse shows physical effects from experimental cancer treatment. Learn about the drug daraxonrasib and its impact on patients.

#BenSasse, #CancerTreatment, #PancreaticCancer, #ExperimentalDrug, #HealthUpdate

https://newsletter.tf/ben-sasse-shows-cancer-treatment-effects-experimental/

Former Senator Ben Sasse revealed severe physical effects from his experimental cancer treatment, showing visible skin and blood damage. This comes as the drug daraxonrasib shows mixed results in trials for advanced pancreatic cancer.

#BenSasse, #CancerTreatment, #PancreaticCancer, #ExperimentalDrug, #HealthUpdate
https://newsletter.tf/ben-sasse-shows-cancer-treatment-effects-experimental/

Ben Sasse Shows Cancer Treatment Effects After Experimental Drug Use

Former Senator Ben Sasse shows physical effects from experimental cancer treatment. Learn about the drug daraxonrasib and its impact on patients.

NewsletterTF

A year ago today I received my diagnosis of pancreatic cancer. Happy to report that I am not dead yet. I have endured chemotherapy and radiation therapy and much weight loss but I’m still standing.

I couldn’t possibly have made it this far without the loving support of my wife and daughter. I am so grateful to have them in my life.

#PancreaticCancer

🌍 World Health Day 2026
“Together for health. Stand with science.”

At SHIELD, we’re advancing a simple blood test for early pancreatic cancer detection, aiming to reduce late diagnoses and improve survival.

Standing with science means saving lives.

#WorldHealthDay #StandWithScience #PancreaticCancer